<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baron</surname>
    <given-names>S. A.</given-names>
   </name>
   <name>
    <surname>Devaux</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Colson</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Raoult</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Rolain</surname>
    <given-names>J. M.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Teicoplanin: an alternative drug for the treatment of COVID-19?</article-title>
  <source>Int. J. Antimicrob. Agents</source>
  <volume>55</volume>:
  <fpage>105944</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105944</pub-id>
  <?supplied-pmid 32179150?>
  <pub-id pub-id-type="pmid">32179150</pub-id>
 </mixed-citation>
</ref>
